Cargando…
miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma
BACKGROUND: As an oncogene, long noncoding RNA metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) can promote tumor metastasis. Hyperexpression of MALAT1 has been observed in many malignant tumors, including hepatocellular carcinoma (HCC). However, the role and mechanism of MALAT1 in HC...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797582/ https://www.ncbi.nlm.nih.gov/pubmed/31466138 http://dx.doi.org/10.1002/cam4.2482 |
_version_ | 1783459859714277376 |
---|---|
author | Cui, Rong‐Jun Fan, Jia‐Lin Lin, Yu‐Cui Pan, Yu‐Jia Liu, Chi Wan, Jia‐Hui Wang, Wei Jiang, Zheng‐Yuan Zheng, Xiu‐Lan Tang, Jie‐Bing Yu, Xiao‐Guang |
author_facet | Cui, Rong‐Jun Fan, Jia‐Lin Lin, Yu‐Cui Pan, Yu‐Jia Liu, Chi Wan, Jia‐Hui Wang, Wei Jiang, Zheng‐Yuan Zheng, Xiu‐Lan Tang, Jie‐Bing Yu, Xiao‐Guang |
author_sort | Cui, Rong‐Jun |
collection | PubMed |
description | BACKGROUND: As an oncogene, long noncoding RNA metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) can promote tumor metastasis. Hyperexpression of MALAT1 has been observed in many malignant tumors, including hepatocellular carcinoma (HCC). However, the role and mechanism of MALAT1 in HCC remain unclear. METHODS: Thirty human HCC and paracancerous tissue specimens were collected, and the human hepatoma cell lines Huh7 and HepG2 were cultured according to standard methods. MALAT1 and Snail family zinc finger (Slug) expression were measured by real‐time PCR, immunohistochemistry, and western blotting. Luciferase reporter assay and RNA immunoprecipitation (RIP) assay verified the direct interaction between miR‐124‐3p and Slug(SNAI2) or MALAT1. Wound healing and transwell assays were performed to examine invasion and migration, and a subcutaneous tumor model was established to measure tumor progression in vivo. RESULTS: MALAT1 expression was upregulated in HCC tissues and positively correlated with Slug expression. MALAT1 and miR‐124‐3p bind directly and reversibly to each other. MALAT1 silencing inhibited cell migration and invasion. miR‐124‐3p inhibited HCC metastasis by targeting Slug. CONCLUSIONS: MALAT1 regulates Slug through miR‐124‐3p, affecting HCC cell metastasis. Thus, the MALAT1/miR‐124‐3p/Slug axis plays an important role in HCC. |
format | Online Article Text |
id | pubmed-6797582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67975822019-10-21 miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma Cui, Rong‐Jun Fan, Jia‐Lin Lin, Yu‐Cui Pan, Yu‐Jia Liu, Chi Wan, Jia‐Hui Wang, Wei Jiang, Zheng‐Yuan Zheng, Xiu‐Lan Tang, Jie‐Bing Yu, Xiao‐Guang Cancer Med Cancer Biology BACKGROUND: As an oncogene, long noncoding RNA metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) can promote tumor metastasis. Hyperexpression of MALAT1 has been observed in many malignant tumors, including hepatocellular carcinoma (HCC). However, the role and mechanism of MALAT1 in HCC remain unclear. METHODS: Thirty human HCC and paracancerous tissue specimens were collected, and the human hepatoma cell lines Huh7 and HepG2 were cultured according to standard methods. MALAT1 and Snail family zinc finger (Slug) expression were measured by real‐time PCR, immunohistochemistry, and western blotting. Luciferase reporter assay and RNA immunoprecipitation (RIP) assay verified the direct interaction between miR‐124‐3p and Slug(SNAI2) or MALAT1. Wound healing and transwell assays were performed to examine invasion and migration, and a subcutaneous tumor model was established to measure tumor progression in vivo. RESULTS: MALAT1 expression was upregulated in HCC tissues and positively correlated with Slug expression. MALAT1 and miR‐124‐3p bind directly and reversibly to each other. MALAT1 silencing inhibited cell migration and invasion. miR‐124‐3p inhibited HCC metastasis by targeting Slug. CONCLUSIONS: MALAT1 regulates Slug through miR‐124‐3p, affecting HCC cell metastasis. Thus, the MALAT1/miR‐124‐3p/Slug axis plays an important role in HCC. John Wiley and Sons Inc. 2019-08-29 /pmc/articles/PMC6797582/ /pubmed/31466138 http://dx.doi.org/10.1002/cam4.2482 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Biology Cui, Rong‐Jun Fan, Jia‐Lin Lin, Yu‐Cui Pan, Yu‐Jia Liu, Chi Wan, Jia‐Hui Wang, Wei Jiang, Zheng‐Yuan Zheng, Xiu‐Lan Tang, Jie‐Bing Yu, Xiao‐Guang miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma |
title | miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma |
title_full | miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma |
title_fullStr | miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma |
title_full_unstemmed | miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma |
title_short | miR‐124‐3p availability is antagonized by LncRNA‐MALAT1 for Slug‐induced tumor metastasis in hepatocellular carcinoma |
title_sort | mir‐124‐3p availability is antagonized by lncrna‐malat1 for slug‐induced tumor metastasis in hepatocellular carcinoma |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797582/ https://www.ncbi.nlm.nih.gov/pubmed/31466138 http://dx.doi.org/10.1002/cam4.2482 |
work_keys_str_mv | AT cuirongjun mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT fanjialin mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT linyucui mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT panyujia mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT liuchi mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT wanjiahui mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT wangwei mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT jiangzhengyuan mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT zhengxiulan mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT tangjiebing mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma AT yuxiaoguang mir1243pavailabilityisantagonizedbylncrnamalat1forsluginducedtumormetastasisinhepatocellularcarcinoma |